• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
Replies
5
Views
429
Replies
4K
Views
1M
Abbott
anonymous
Replies
5
Views
501
Replies
34
Views
7K
Replies
13
Views
1K
Replies
33
Views
5K
Replies
11
Views
488